Nicotine

• 

  Subject Areas on Research

  • A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. 
  • A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. 
  • A programmable smoke delivery device for PET imaging with cigarettes containing 11C-nicotine. 
  • A psychometric evaluation of the Fagerström Test for Nicotine Dependence in PTSD smokers. 
  • A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. 
  • A study of the potential confounding effects of diet, caffeine, nicotine and lorazepam on the stability of plasma and urinary homovanillic acid levels in patients with schizophrenia. 
  • A unique role for striatal serotonergic systems in the withdrawal from adolescent nicotine administration. 
  • ADHD and smoking: from genes to brain to behavior. 
  • Acoustic startle and prepulse inhibition predict smoking lapse in posttraumatic stress disorder. 
  • Activity patterns in mesolimbic regions in rats during operant tasks for reward. 
  • Acute and chronic effects of nicotine on synthesis and storage of catecholamines in the rat adrenal medulla. 
  • Acute and chronic interactive treatments of serotonin 5HT2C and dopamine D1 receptor systems for decreasing nicotine self-administration in female rats. 
  • Acute and chronic nicotine effects on working memory in aged rats. 
  • Acute and chronic nicotinic interactions with dopamine systems and working memory performance. 
  • Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking. 
  • Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. 
  • Acute oral 18-methoxycoronaridine (18-MC) decreases both alcohol intake and IV nicotine self-administration in rats. 
  • Acute stimulation of ornithine decarboxylase in neonatal rat brain regions by nicotine: a central receptor-mediated process? 
  • Additive and synergistic effects of fetal nicotine and dexamethasone exposure on cholinergic synaptic function in adolescence and adulthood: Implications for the adverse consequences of maternal smoking and pharmacotherapy of preterm delivery. 
  • Adherence to nicotine replacement therapy among pregnant smokers. 
  • Administration of nicotine to adolescent rats evokes regionally selective upregulation of CNS alpha 7 nicotinic acetylcholine receptors. 
  • Adolescent and adult rats respond differently to nicotine and alcohol: motor activity and body temperature. 
  • Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. 
  • Adolescent nicotine administration changes the responses to nicotine given subsequently in adulthood: adenylyl cyclase cell signaling in brain regions during nicotine administration and withdrawal, and lasting effects. 
  • Adolescent nicotine exposure alters cardiac autonomic responsiveness: beta-adrenergic and m2-muscarinic receptors and their linkage to adenylyl cyclase. 
  • Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. 
  • Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. 
  • Adolescent nicotine treatment changes the response of acetylcholine systems to subsequent nicotine administration in adulthood. 
  • Adolescent nicotine: deficits in immune function. 
  • Adolescent vs. adult-onset nicotine self-administration in male rats: duration of effect and differential nicotinic receptor correlates. 
  • Adolescent vulnerabilities to chronic alcohol or nicotine exposure: findings from rodent models. 
  • Adolescent-onset nicotine self-administration modeled in female rats. 
  • Adolescents and adults differ in the immediate and long-term impact of nicotine administration and withdrawal on cardiac norepinephrine. 
  • Adverse benzo[a]pyrene effects on neurodifferentiation are altered by other neurotoxicant coexposures: interactions with dexamethasone, chlorpyrifos, or nicotine in PC12 cells. 
  • Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial. 
  • Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler. 
  • Alpha7 nicotinic acetylcholine receptors targeted by cholinergic developmental neurotoxicants: nicotine and chlorpyrifos. 
  • Alteration of the alkaloid profile in genetically modified tobacco reveals a role of methylenetetrahydrofolate reductase in nicotine N-demethylation. 
  • Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. 
  • Ameliorating the developmental neurotoxicity of chlorpyrifos: a mechanisms-based approach in PC12 cells. 
  • Amelioration strategies fail to prevent tobacco smoke effects on neurodifferentiation: Nicotinic receptor blockade, antioxidants, methyl donors. 
  • Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats. 
  • Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats. 
  • An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. 
  • Analysis of reinforcement by varying smoke component concentrations. 
  • Anticipated Effects of Nicotine Reduction on Youth Smoking Initiation and Maintenance. 
  • Antidepressant effects of nicotine in an animal model of depression. 
  • Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. 
  • Anxiolytic effects of nicotine in zebrafish. 
  • Appeal, subjective effects, and relative reinforcing effects of JUUL that vary in flavor and nicotine content. 
  • Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: implications for addiction. 
  • Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats. 
  • Asthma exacerbation after administration of nicotine nasal spray for smoking cessation. 
  • Attention as a target of intoxication: insights and methods from studies of drug abuse. 
  • Baclofen interactions with nicotine in rats: effects on memory. 
  • Baseline expression of alpha4beta2* nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. 
  • Basic Science and Public Policy: Informed Regulation for Nicotine and Tobacco Products. 
  • Behavioral effects of acute hexamethonium in rats chronically intoxicated with nicotine. 
  • Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. 
  • Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets. 
  • Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. 
  • Bupropion-varenicline interactions and nicotine self-administration behavior in rats. 
  • Bupropion/zonisamide combination to assist smokers to switch from combustible cigarettes to electronic nicotine delivery systems (ENDS). 
  • CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury: A Multicenter Cohort of 160 Cases. 
  • Capsaicin and nicotine both activate a subset of rat trigeminal ganglion neurons. 
  • Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. 
  • Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. 
  • Characterization of the facilitative effects of perinatal choline supplementation on timing and temporal memory. 
  • Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. 
  • Cholinergic and adrenergic activating agents as antagonists of the EEG effects of hemicholinium-3. 
  • Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. 
  • Cholinergic stimulation of phosphatidylinositol hydrolysis by rat corneal epithelium in vitro. 
  • Cholinergic synaptic signaling mechanisms underlying behavioral teratogenicity: effects of nicotine, chlorpyrifos, and heroin converge on protein kinase C translocation in the intermedial part of the hyperstriatum ventrale and on imprinting behavior in an avian model. 
  • Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. 
  • Chronic exposure to nicotine does not prevent neurocognitive decline after cardiac surgery. 
  • Chronic haloperidol administration does not block acute nicotine-induced improvements in radial-arm maze performance in the rat. 
  • Chronic infusions of mecamylamine into the medial habenula: Effects on nicotine self-administration in rats. 
  • Chronic inhibition of alpha4beta2 nicotinic receptors in the ventral hippocampus of rats: impacts on memory and nicotine response. 
  • Chronic memantine decreases nicotine self-administration in rats. 
  • Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats. 
  • Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding. 
  • Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats. 
  • Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. 
  • Chronic nicotine interactions with clozapine and risperidone and attentional function in rats. 
  • Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. 
  • Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs. 
  • Chronic nicotinic agonist and antagonist effects on T-maze alternation. 
  • Chronic prenatal nicotine exposure sensitizes rat brain to acute postnatal nicotine challenge as assessed with ornithine decarboxylase. 
  • Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain. 
  • Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. 
  • Cigarette desirability and nicotine preference in smokers. 
  • Cigarette smoking behavior in conjoined twins. 
  • Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. 
  • Citric acid aerosol as a potential smoking cessation aid. 
  • Clinical evaluation of a citric acid inhaler for smoking cessation. 
  • Clinical trials using ascorbic acid aerosol to aid smoking cessation. 
  • Clozapine treatment reverses dizocilpine-induced deficits of pre-pulse inhibition of tactile startle response. 
  • Co-expression of nAChRs and molecules of the bitter taste transduction pathway by epithelial cells of intrapulmonary airways. 
  • Cognitive and Behavioral Impairments Evoked by Low-Level Exposure to Tobacco Smoke Components: Comparison with Nicotine Alone. 
  • Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. 
  • Cognitive effects of nicotine. 
  • Combined acetaldehyde and nicotine exposure depresses cardiac contraction in ventricular myocytes: prevention by folic acid. 
  • Combined administration of agonist-antagonist as a method of regulating receptor activation. 
  • Comparison of brain nicotine uptake from electronic cigarettes and combustible cigarettes. 
  • Conditional expression in corticothalamic efferents reveals a developmental role for nicotinic acetylcholine receptors in modulation of passive avoidance behavior. 
  • Consequences of smoking during pregnancy on maternal health. 
  • Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes. 
  • Cortical activity differs during nicotine deprivation versus satiation in heavy smokers. 
  • Cost-effectiveness analysis of the first-line therapies for nicotine dependence. 
  • Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison. 
  • Critical review: nicotine for the fetus, the infant and the adolescent? 
  • Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. 
  • D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response. 
  • Deficits in development of central cholinergic pathways caused by fetal nicotine exposure: differential effects on choline acetyltransferase activity and [3H]hemicholinium-3 binding. 
  • Depressive characteristics of FSL rats: involvement of central nicotinic receptors. 
  • Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. 
  • Developing fit-for-purpose self-report instruments for assessing consumer responses to tobacco and nicotine products: the ABOUT™ Toolbox initiative. 
  • Development and Piloting Testing of an Experimental Tobacco and Nicotine Product Marketplace. 
  • Development of [3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions. 
  • Development of a citric acid aerosol as a smoking cessation aid. 
  • Development of ligands for in vivo imaging of cerebral nicotinic receptors. 
  • Development of nicotinic drug therapy for cognitive disorders. 
  • Development of nicotinic responses in the rat adrenal medulla and long-term effects of neonatal nicotine administration. 
  • Developmental Neurotoxicity of Tobacco Smoke Directed Toward Cholinergic and Serotonergic Systems: More Than Just Nicotine. 
  • Developmental cholinotoxicants: nicotine and chlorpyrifos. 
  • Developmental nicotine exposure and masculinization of the rat preoptic area. 
  • Developmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products. 
  • Dextromethorphan interactions with histaminergic and serotonergic treatments to reduce nicotine self-administration in rats. 
  • Did the acute impact of the COVID-19 pandemic on drinking or nicotine use persist? Evidence from a cohort of emerging adults followed for up to nine years. 
  • Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats. 
  • Differential efficacies of the nicotinic α4β2 desensitizing agents in reducing nicotine self-administration in female rats. 
  • Discriminability of nicotine in tobacco smoke: implications for titration. 
  • Disrupting nicotine reinforcement: from cigarette to brain. 
  • Dissociating nicotine and nonnicotine components of cigarette smoking. 
  • Dissociating the nicotine and airway sensory effects of smoking. 
  • Diverse neurotoxicants target the differentiation of embryonic neural stem cells into neuronal and glial phenotypes. 
  • Do heavy smokers need a higher replacement dose of nicotine to quit? 
  • Does concurrent or prior nicotine exposure interact with neonatal hypoxia to produce cardiac cell damage? 
  • Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence? 
  • Does smokeless tobacco cause hypertension? 
  • Dynamic and multimodal responses of gustatory cortical neurons in awake rats. 
  • EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependence. 
  • Editorial: Smoking, catecholamines, and the heart. 
  • Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. 
  • Effect of naloxone on cigarette smoking. 
  • Effects of advertisements on smokers' interest in trying e-cigarettes: the roles of product comparison and visual cues. 
  • Effects of caffeine on alcohol consumption and nicotine self-administration in rats. 
  • Effects of chronic nicotine administration on the denervated rat adrenal medulla. 
  • Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. 
  • Effects of controlled nicotine doses upon punished and non-punished responding in humans. 
  • Effects of low nicotine content cigarettes on smoke intake. 
  • Effects of maternal nicotine injections on brain development in the rat: ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions. 
  • Effects of monetary contingencies on smoking relapse: influences of trait depression, personality, and habitual nicotine intake. 
  • Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats. 
  • Effects of nicotine on brain responses to emotional pictures. 
  • Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. 
  • Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. 
  • Effects of postnatal reserpine administration on sympatho-adrenal development in the rat. 
  • Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. 
  • Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. 
  • Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways. 
  • Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of rhesus monkeys. 
  • Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. 
  • Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence. 
  • Effects of reserpine on the adrenal medulla of the spontaneously hypertensive rat. 
  • Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. 
  • Effects of sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, on body temperature regulation in mice and rats. 
  • Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. 
  • Effects of smoking on the acoustic startle response and prepulse inhibition in smokers with and without posttraumatic stress disorder. 
  • Effects of tobacco smoke on PC12 cell neurodifferentiation are distinct from those of nicotine or benzo[a]pyrene. 
  • Effects of tobacco smoking and nicotine on cancer treatment. 
  • Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans. 
  • Effects of transdermal nicotine on lateralized identification and memory interference. 
  • Electronic Cigarettes: A Pro-Con Review of the Current Literature. 
  • Electronic cigarette liquid exposure induces flavor-dependent osteotoxicity and increases expression of a key bone marker, collagen type I. 
  • Emergence of depression during early abstinence in depressed and non-depressed women smokers. 
  • Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use. 
  • Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review. 
  • Exposure to environmental tobacco smoke during pregnancy in rats yields less effect on indices of brain cell number and size than does postnatal exposure. 
  • Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. 
  • Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. 
  • Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions. 
  • Fetal nicotine exposure alters ontogeny of M1-receptors and their link to G-proteins. 
  • Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. 
  • Fetal nicotine or cocaine exposure: which one is worse? 
  • Fetal nicotinic overload, blunted sympathetic responsivity, and obesity. 
  • Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. 
  • Gain modulation by nicotine in macaque v1. 
  • Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement. 
  • Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. 
  • Gestational exposure to nicotine and/or benzo[a]pyrene causes long-lasting neurobehavioral consequences. 
  • Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380. 
  • Guidelines on nicotine dose selection for in vivo research. 
  • Haloperidol increases smoking in patients with schizophrenia. 
  • Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes. 
  • Heterogeneity across brain regions and neurotransmitter interactions with nicotinic effects on memory function. 
  • Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats. 
  • Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine. 
  • Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond. 
  • IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs. 
  • IV nicotine self-administration in rats using the consummatory operant licking response. 
  • Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine. 
  • Identification of muscarinic acetylcholine receptors in isolated canine lingual epithelia via voltage clamp measurements. 
  • If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? 
  • Impact of acute nicotine exposure on monoaminergic systems in adolescent and adult male and female rats. 
  • Impact of adolescent nicotine exposure on adenylyl cyclase-mediated cell signaling: enzyme induction, neurotransmitter-specific effects, regional selectivities, and the role of withdrawal. 
  • Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal? 
  • Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates. 
  • Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for sudden infant death syndrome. 
  • Improvement of attentional function with antagonism of nicotinic receptors in female rats. 
  • In search of a mechanism for receptor-mediated neurobehavioral teratogenesis by nicotine: catecholamine release by nicotine in immature rat brain regions. 
  • In utero exposure to nicotine and chlorpyrifos alone, and in combination produces persistent sensorimotor deficits and Purkinje neuron loss in the cerebellum of adult offspring rats. 
  • In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. 
  • Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. 
  • Increased nicotine self-administration following prenatal exposure in female rats. 
  • Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use. 
  • Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility. 
  • Induction of tyrosine hydroxylase in the locus coeruleus of transgenic mice in response to stress or nicotine treatment: lack of activation of tyrosine hydroxylase promoter activity. 
  • Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms. 
  • Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. 
  • Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. 
  • Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task. 
  • Invalidity of an Oft-Cited Estimate of the Relative Harms of Electronic Cigarettes. 
  • Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats? 
  • Ketanserin attenuates nicotine-induced working memory improvement in rats. 
  • Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats. 
  • Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine. 
  • Lasting effects of nicotine treatment and withdrawal on serotonergic systems and cell signaling in rat brain regions: separate or sequential exposure during fetal development and adulthood. 
  • Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats. 
  • Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for sudden infant death syndrome. 
  • Low-dose mecamylamine improves learning of rats in the radial-arm maze repeated acquisition procedure. 
  • Low-nicotine regenerated smoke aerosol reduces desire for cigarettes. 
  • Maternal prenatal depressive symptoms, nicotine addiction, and smoking-related knowledge, attitudes, beliefs, and behaviors. 
  • Maternal tobacco smoking, nicotine replacement and neurobehavioural development. 
  • Mecamylamine acutely increases human intravenous nicotine self-administration. 
  • Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. 
  • Mecamylamine increases cigarette smoking in psychiatric patients. 
  • Mecamylamine increases nicotine preference and attenuates nicotine discrimination. 
  • Menthol decreases oral nicotine aversion in C57BL/6 mice through a TRPM8-dependent mechanism. 
  • Menthol disrupts nicotine's psychostimulant properties in an age and sex-dependent manner in C57BL/6J mice. 
  • Menthol preference moderates the relationship between cigarette nicotine content choice and reactions in young adults who smoke infrequently. 
  • Metallothionein expression and neurocognitive function in mice. 
  • Mimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuits. 
  • Mimicking maternal smoking and pharmacotherapy of preterm labor: interactions of fetal nicotine and dexamethasone on serotonin and dopamine synaptic function in adolescence and adulthood. 
  • Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction--developmental neurotoxicity of nicotine. 
  • Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. 
  • Modeling the developmental neurotoxicity of nicotine in vitro: cell acquisition, growth and viability in PC12 cells. 
  • Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors. 
  • Molecular genetics of successful smoking cessation: convergent genome-wide association study results. 
  • Multiple brain pathways and receptors underlying tobacco addiction. 
  • Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats. 
  • NIH electronic cigarette workshop: developing a research agenda. 
  • NMDA systems in the amygdala and piriform cortex and nicotinic effects on memory function. 
  • Naltrexone blockade of nicotine effects in cigarette smokers. 
  • National working conference on smoking and body weight. Task Force 2: Methods of assessment, strategies for research. 
  • Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration. 
  • Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats. 
  • Neuroanatomical circuitry mediating the sensory impact of nicotine in the central nervous system. 
  • Neurobehavioral impairments caused by developmental imidacloprid exposure in zebrafish. 
  • New findings on nicotine addiction and treatment. 
  • Nicotine Withdrawal Induces Neural Deficits in Reward Processing. 
  • Nicotine activates TRPM5-dependent and independent taste pathways. 
  • Nicotine addiction and treatment. 
  • Nicotine administration in adolescence reprograms the subsequent response to nicotine treatment and withdrawal in adulthood: sex-selective effects on cerebrocortical serotonergic function. 
  • Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). 
  • Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade. 
  • Nicotine and clozapine effects on attentional performance impaired by the NMDA antagonist dizocilpine in female rats. 
  • Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. 
  • Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling. 
  • Nicotine and nonnicotine factors in cigarette addiction. 
  • Nicotine and the adolescent brain: insights from an animal model. 
  • Nicotine as a therapeutic drug. 
  • Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia. 
  • Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. 
  • Nicotine deprivation influences P300 markers of cognitive control. 
  • Nicotine does not enhance tumorigenesis in mutant K-ras-driven mouse models of lung cancer. 
  • Nicotine effects on adults with attention-deficit/hyperactivity disorder. 
  • Nicotine effects on learning in zebrafish: the role of dopaminergic systems. 
  • Nicotine enhances stimulus detection performance of middle- and old-aged rats: a longitudinal study. 
  • Nicotine evokes cell death in embryonic rat brain during neurulation. 
  • Nicotine exposure in adolescence alters the response of serotonin systems to nicotine administered subsequently in adulthood. 
  • Nicotine for postoperative analgesia: a systematic review and meta-analysis. 
  • Nicotine increases anterior insula activation to expected and unexpected outcomes among nonsmokers. 
  • Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution. 
  • Nicotine increases size and severity of experimental choroidal neovascularization. 
  • Nicotine inhibits voltage-dependent sodium channels and sensitizes vanilloid receptors. 
  • Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. 
  • Nicotine interactions with low-dose alcohol: pharmacological influences on smoking and drinking motivation. 
  • Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos. 
  • Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations. 
  • Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes. 
  • Nicotine preference increases after cigarette deprivation. 
  • Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior. 
  • Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. 
  • Nicotine self-administration in animals and humans: similarities and differences. 
  • Nicotine skin patch treatment and adverse reactions: skin irritation, skin sensitization, and nicotine as a hapten. 
  • Nicotine skin patch treatment increases abstinence, decreases withdrawal symptoms, and attenuates rewarding effects of smoking. 
  • Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital. 
  • Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. 
  • Nicotine withdrawal modulates frontal brain function during an affective Stroop task. 
  • Nicotine-alcohol interactions and attentional performance on an operant visual signal detection task in female rats. 
  • Nicotine-alcohol interactions and cognitive function in rats. 
  • Nicotine-antipsychotic drug interactions and attentional performance in female rats. 
  • Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze. 
  • Nicotine-haloperidol interactions and cognitive performance in schizophrenics. 
  • Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. 
  • Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. 
  • Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals. 
  • Nicotinic acetylcholine receptor stimulation impairs epidermal permeability barrier function and recovery and modulates cornified envelope proteins. 
  • Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. 
  • Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. 
  • Nicotinic antagonist effects in the mediodorsal thalamic nucleus: regional heterogeneity of nicotinic receptor involvement in cognitive function. 
  • Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. 
  • Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. 
  • Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. 
  • Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. 
  • Nicotinic involvement in memory function in zebrafish. 
  • Nicotinic receptor subtypes and cognitive function. 
  • Nicotinic receptors in the habenula: importance for memory. 
  • Nicotinic stimulation of splenic T cells is protective in endoscopic retrograde cholangiopancreatography-induced acute pancreatitis in mice. 
  • Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. 
  • Nicotinic systems and cognitive function. 
  • Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. 
  • Nicotinic-antipsychotic drug interactions and cognitive function. 
  • Nicotinic-glutamatergic interactions and attentional performance on an operant visual signal detection task in female rats. 
  • Nicotinic-serotonergic drug interactions and attentional performance in rats. 
  • Non-neurogenic adrenal catecholamine release in the neonatal rat: exocytosis or diffusion? 
  • Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategy. 
  • Olanzapine interactions with nicotine and mecamylamine in rats: effects on memory function. 
  • Olfactory cue reactivity in nicotine-dependent adult smokers. 
  • Oral nicotine solution for smoking cessation: a pilot tolerability study. 
  • Oral sazetidine-A, a selective α4β2* nicotinic receptor desensitizing agent, reduces nicotine self-administration in rats. 
  • Ornithine decarboxylase in developing rat heart and brain: role of sympathetic development for responses to autonomic stimulants and the effects of reserpine on maturation. 
  • Outcomes from an outpatient smoking-cessation clinic. 
  • Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. 
  • PET studies of the influences of nicotine on neural systems in cigarette smokers. 
  • Parasympathetic stimulation via the vagus nerve prevents systemic organ dysfunction by abrogating gut injury and lymph toxicity in trauma and hemorrhagic shock. 
  • Paternal nicotine exposure in rats produces long-lasting neurobehavioral effects in the offspring. 
  • Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks. 
  • Pergolide interactions with nicotine and pilocarpine in rats on the radial-arm maze. 
  • Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. 
  • Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at 6 months of age. 
  • Persistence of chronic nicotine-induced cognitive facilitation. 
  • Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. 
  • Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH-23390 or the serotonin 5-HT2C agonist lorcaserin. 
  • Persistent c-fos induction by nicotine in developing rat brain regions: interaction with hypoxia. 
  • Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. 
  • Pharmacologic and sensorimotor components of satiation in cigarette smoking. 
  • Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. 
  • Potentiation of nicotine reward by alcohol. 
  • Practice guideline for the treatment of patients with nicotine dependence. American Psychiatric Association. 
  • Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field. 
  • Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment. 
  • Precessation treatment with nicotine skin patch facilitates smoking cessation. 
  • Preliminary Evaluation of Short-Term Abstinence Effects Among Never-Smoking Experienced Users of Modern Electronic Cigarettes. 
  • Preliminary findings from a clinical demonstration project for veterans returning from Iraq or Afghanistan. 
  • Prenatal cocaine and/or nicotine exposure in rats: preliminary findings on long-term cognitive outcome and genital development at birth. 
  • Prenatal drug exposures sensitize noradrenergic circuits to subsequent disruption by chlorpyrifos. 
  • Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. 
  • Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. 
  • Prenatal nicotine alters the developmental neurotoxicity of postnatal chlorpyrifos directed toward cholinergic systems: better, worse, or just "different?". 
  • Prenatal nicotine changes the response to postnatal chlorpyrifos: Interactions targeting serotonergic synaptic function and cognition. 
  • Prenatal nicotine effects on memory in rats: pharmacological and behavioral challenges. 
  • Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. 
  • Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling. 
  • Prenatal nicotine exposure and cognitive performance in rats. 
  • Prenatal nicotine exposure evokes alterations of cell structure in hippocampus and somatosensory cortex. 
  • Prenatal nicotine exposure impairs beta-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. 
  • Prenatal nicotine exposure in rhesus monkeys compromises development of brainstem and cardiac monoamine pathways involved in perinatal adaptation and sudden infant death syndrome: amelioration by vitamin C. 
  • Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the pre-weanling rat. 
  • Prevalence, Trends, and Distribution of Nicotine and Marijuana use in E-cigarettes among US adults: The Behavioral Risk Factor Surveillance System 2016-2018. 
  • Prolonged nicotine patch use in quitters with past abstinence-induced depressed mood. 
  • Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions. 
  • Psychopharmacological interactions between nicotine and ethanol. 
  • Psychophysiological interactions between caffeine and nicotine. 
  • Public health clinical demonstration project for smoking cessation in american veterans who served since september 11, 2001. 
  • Public health clinical demonstration project for smoking cessation in veterans with posttraumatic stress disorder. 
  • Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics. 
  • Randomized Trial of Reduced-Nicotine Standards for Cigarettes. 
  • Randomized trial comparing mindfulness training for smokers to a matched control. 
  • Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. 
  • Rapid Brain Nicotine Uptake from Electronic Cigarettes. 
  • Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers. 
  • Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes. 
  • Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats. 
  • Refined cigarette smoke as a method for reducing nicotine intake. 
  • Reinforcing effects of nicotine and non-nicotine components of cigarette smoke. 
  • Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers. 
  • Responses to Gradual and Immediate Reduction of Nicotine in Cigarettes in Young Versus Older Adult Smokers. 
  • Reversal of chlorpyrifos neurobehavioral teratogenicity in mice by nicotine administration and neural stem cell transplantation. 
  • Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions. 
  • Role of insular cortex D₁ and D₂ dopamine receptors in nicotine self-administration in rats. 
  • Role of nicotine dose and sensory cues in the regulation of smoke intake. 
  • Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats. 
  • Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. 
  • Saliva nicotine as an index of plasma levels in nicotine skin patch users. 
  • Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. 
  • Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: results of a preliminary functional magnetic resonance imaging study. 
  • Selectivity of lingual nerve fibers to chemical stimuli. 
  • Self-administration by female rats of low doses of nicotine alone vs. nicotine in tobacco smoke extract. 
  • Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats. 
  • Separate or sequential exposure to nicotine prenatally and in adulthood: persistent effects on acetylcholine systems in rat brain regions. 
  • Sertraline attenuates hyperphagia in rats following nicotine withdrawal. 
  • Sex differences in response to nicotine in C57Bl/6:129SvEv mice. 
  • Sex-selective hippocampal alterations after adolescent nicotine administration: effects on neurospecific proteins. 
  • Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior. 
  • Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds. 
  • Short-term adolescent nicotine exposure in rats elicits immediate and delayed deficits in T-lymphocyte function: critical periods, patterns of exposure, dose thresholds. 
  • Should managed care organizations pay for nicotine replacement therapy? 
  • Silver acetate interactions with nicotine and non-nicotine smoke components. 
  • Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study. 
  • Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes. 
  • Smoking abstinence and neurocognition: implications for cessation and relapse. 
  • Smoking and anxiety in combat veterans with chronic posttraumatic stress disorder: a review. 
  • Smoking and ischemic stroke: a role for nicotine? 
  • Smoking and therapeutic response to clozapine in patients with schizophrenia. 
  • Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances. 
  • Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition. 
  • Smoking withdrawal symptoms in response to a trauma-related stressor among Vietnam combat veterans with posttraumatic stress disorder. 
  • Sperm DNA methylation altered by THC and nicotine: Vulnerability of neurodevelopmental genes with bivalent chromatin. 
  • Strain-specific altered nicotine metabolism in 3,3'-diindolylmethane (DIM) exposed mice. 
  • Stress alleviation and reward enhancement: two promising targets for relapse prevention. 
  • Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats. 
  • Subchronic effects of plant alkaloids on anxiety-like behavior in zebrafish. 
  • Sugars and Sweeteners in Tobacco and Nicotine Products: Food and Drug Administration's Regulatory Implications. 
  • Supplemental nicotine preloading for smoking cessation in posttraumatic stress disorder: Results from a randomized controlled trial. 
  • Support for a nicotine reduction policy among participants enrolled in a 20-week trial of very low nicotine content cigarettes. 
  • Symposium overview: mechanism of action of nicotine on neuronal acetylcholine receptors, from molecule to behavior. 
  • Synthetic nicotine has arrived. 
  • Taste-specific neuronal ensembles in the gustatory cortex of awake rats. 
  • Teratogenic, bioenergetic, and behavioral effects of exposure to total particulate matter on early development of zebrafish (Danio rerio) are not mimicked by nicotine. 
  • The Agency for Health Care Policy and Research Smoking Cessation Clinical Practice Guideline. 
  • The Developmental Neurotoxicity of Tobacco Smoke Can Be Mimicked by a Combination of Nicotine and Benzo[a]Pyrene: Effects on Cholinergic and Serotonergic Systems. 
  • The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report. 
  • The Effects of Nicotine and Tobacco Use on Brain Reward Function: Interaction With Nicotine Dependence Severity. 
  • The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings. 
  • The Tobacco 21 Movement and Electronic Nicotine Delivery System Use Among Youth. 
  • The biology of tobacco and nicotine: bench to bedside. 
  • The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans. 
  • The effect of cigarette smoke extract on trophoblast cell viability and migration: the role of adrenomedullin. 
  • The effect of nicotine and trauma context on acoustic startle in smokers with and without posttraumatic stress disorder. 
  • The effect of nicotine on the delay of gastric emptying. 
  • The effects of nicotine and non-nicotine smoking factors on working memory and associated brain function. 
  • The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin. 
  • The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults. 
  • The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. 
  • The long-term effects of prenatal nicotine exposure on neurologic development. 
  • The marketing of dissolvable tobacco: social science and public policy research needs. 
  • The nicotine patch in smoking cessation. A randomized trial with telephone counseling. 
  • The role of alpha7 and alpha4beta2 nicotinic receptors in the nicotine-induced anxiolytic effect in zebrafish. 
  • The role of upper airway stimulation in smoking. 
  • The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. 
  • The use of flavor in cigarette substitutes. 
  • This is your teen brain on drugs: In search of biological factors unique to dependence toxicity in adolescence. 
  • Threshold of adulthood for the onset of nicotine self-administration in male and female rats. 
  • Thymocytes and cultured thymic epithelial cells express transcripts encoding alpha-3, alpha-5, and beta-4 subunits of neuronal nicotinic acetylcholine receptors. Preferential transcription of the alpha-3 and beta-4 genes by immature CD4+8+ thymocytes and evidence for response to nicotine in thymocytes. 
  • Time-dependent effects of nicotine on reversal of dizocilpine-induced attentional impairment in female rats. 
  • Timing of nicotine effects on learning in zebrafish. 
  • Tobacco Withdrawal Symptoms Before and After Nicotine Deprivation in Veteran Smokers with Posttraumatic Stress Disorder and with Major Depressive Disorder. 
  • Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. 
  • Transcranial Direct Current Stimulation Applied to the Dorsolateral and Ventromedial Prefrontal Cortices in Smokers Modifies Cognitive Circuits Implicated in the Nicotine Withdrawal Syndrome. 
  • Transdermal administration of nicotine. 
  • Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. 
  • Transdermal nicotine effects on attention. 
  • Transdermal nicotine facilitates smoking cessation. 
  • Transdermal nicotine for analgesia after radical retropubic prostatectomy. 
  • Transdermal nicotine reduces cigarette craving and nicotine preference. 
  • Transdermal nicotine replacement in pregnancy: maternal pharmacokinetics and fetal effects. 
  • Twenty-Four-Hour Cardiovascular Effects of Electronic Cigarettes Compared With Cigarette Smoking in Dual Users. 
  • Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380. 
  • Ventral hippocampal NMDA blockade and nicotinic effects on memory function. 
  • Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze. 
  • Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory. 
  • Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats. 
  • Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats. 
  • Very Low Nicotine Content Cigarettes Disrupt the Feedback Loop of Affective States and Smoking Behavior. 
  • Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health. 
  • Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra. 
  • Young adult dual combusted cigarette and e-cigarette users' anticipated responses to a nicotine reduction policy and menthol ban in combusted cigarettes. 
  • Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development. 
  • Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. 
  • alpha7 Nicotinic acetylcholine receptors and temporal memory: synergistic effects of combining prenatal choline and nicotine on reinforcement-induced resetting of an interval clock. 
• 

  Keywords of People

  • Dedert, Eric, Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
  • Jabba, Sairam V., Research Scientist, Anesthesiology
  • McClernon, F Joseph, Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine & Neurosciences
  • Oliver, Jason A, Adjunct Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology
  • Rubenstein, Dana, Student, Psychiatry & Behavioral Sciences
  • Schwartz-Bloom, Rochelle D., Professor Emeritus of Pharmacology & Cancer Biology, Duke Science & Society
  • Turkington, Timothy Garvey, Associate Professor in Radiology, Radiology